Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
about
Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lungAssociation of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer StudyEpigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and MetastasisLoss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival.Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition.TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling.RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.TUSC3: a novel tumour suppressor gene and its functional implications.Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer.TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signalingRacial health disparities in ovarian cancer: not just black and white.Tumor suppressor candidate TUSC3 expression during rat testis maturation.TUSC3: functional duality of a cancer gene.Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.Tumor suppressor candidate 3: A novel grading tool and predictor of clinical malignancy in human gliomas.
P2860
Q34795438-57B388DF-296B-474C-8EAE-B6DBB263705BQ35004607-973FBF6D-554E-43BC-90AD-CCE8C21DC86CQ35011670-81DE4FFE-3D23-493A-BD0F-AB7C62716277Q35674941-5DE51990-EF66-4442-8063-57304DFE7B52Q35726371-D542753C-BD1F-4C67-A07E-C1B60E221AB6Q35922334-651FD1BB-ECD8-46AA-B7C4-D6DC919DE1A6Q37452286-E1788093-D5A4-46BE-ABD5-B1764257AD5AQ37641812-B2BC2E16-86BC-4D40-90F1-F77C427D99DBQ37697914-62D720DE-4D19-4FCF-B77D-53302B1F60BBQ38728330-2015A19F-6676-422E-BDDD-0901E72112E2Q38737107-F77EFBC4-4EB6-46E4-AFF8-0C0F5EEF8208Q38778821-057E4A27-912B-4C56-8274-92D740BD8F0CQ38852995-31D5EC16-D7D8-4435-9AAD-70D2FA2CB77FQ38904136-22E95D7B-CAF4-4969-9C4F-2335AD42B242Q38994193-7FD162D0-FCBB-48CD-AF3E-1D147CC34488Q39033641-B8DC9F56-C9F2-47BF-9606-CD54512F6CC6Q39096966-00CE13B4-02B7-4A54-9907-EBCDF4E52429Q39168284-3DD5C898-FAAE-4D86-8C59-6BE358C24A90Q41195127-BC184974-A8B1-43A3-8C1A-2F9243B45A45Q41592988-D8FCE726-33A5-4642-9BD3-53BD573542CEQ41696304-B141DA99-67C6-4378-BCB9-46621A20F252Q45376336-4A475ED9-2B7E-4D3F-8AEC-9430B1FFFBBBQ47774283-AEFFE9ED-C69B-4C74-963D-B697DBA59DDFQ50335868-8ACF0611-8F21-430F-BF0F-B09A4A775E99Q52647708-1D115BA8-8957-4AFF-ADB8-220953748398
P2860
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@en
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@nl
type
label
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@en
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@nl
prefLabel
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@en
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
@en
P2093
Andreas Gleiss
Angela Alfanz
Elena-Ioana Braicu
Mariam Anees
Michael Wittinger
Veronika Auner
P2860
P304
P356
10.1002/CNCR.27850
P407
P50
P577
2012-10-23T00:00:00Z